Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP).
Meissner Y, Strangfeld A, Molto A, Forger F, Wallenius M, Costedoat-Chalumeau N, Bjørngaard H, Couderc M, Flipo RM, Guettrot-Imbert G, Haase I, Jakobsen B, Koksvik HSS, Richez C, Sellam J, Weiß A, Zbinden A, Fischer-Betz R; EuNeP collaborator group. Meissner Y, et al. Among authors: couderc m. Ann Rheum Dis. 2022 Nov;81(11):1524-1533. doi: 10.1136/ard-2022-222641. Epub 2022 Aug 12. Ann Rheum Dis. 2022. PMID: 35961759
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.
Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M; Club Rhumatismes et Inflammations. Couderc M, et al. Rheumatology (Oxford). 2014 Oct;53(10):1788-93. doi: 10.1093/rheumatology/keu176. Epub 2014 May 11. Rheumatology (Oxford). 2014. PMID: 24821852
Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France).
Soubrier M, Pereira B, Fan A, Frayssac T, Couderc M, Malochet-Guinamand S, Mathieu S, Tatar Z, Tournadre A, Dubost JJ. Soubrier M, et al. Among authors: couderc m. Int J Rheum Dis. 2018 Nov;21(11):1986-1992. doi: 10.1111/1756-185X.13375. Epub 2018 Aug 30. Int J Rheum Dis. 2018. PMID: 30168265 Free PMC article.
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.
Felten R, Duret PM, Bauer E, Sedmak N, Djossou JH, Bensalem M, Ardizzone M, Geoffroy M, Fan A, Couderc M, Salmon JH, Messer L, Javier RM, Meyer A, Chatelus E, Sordet C, Pijnenburg L, Fort J, Rinagel M, Walther J, Fabre C, Arnaud L, Sibilia J, Meyer N, Berenbaum F, Chary-Valckenaere I, Soubrier M, Sellam J, Gottenberg JE. Felten R, et al. Among authors: couderc m. Ann Rheum Dis. 2022 Jan;81(1):143-145. doi: 10.1136/annrheumdis-2021-220549. Epub 2021 Sep 23. Ann Rheum Dis. 2022. PMID: 34556483 No abstract available.
Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
Dubost JJ, Couderc M, Pereira B, Mariette X, Seror R, Gottenberg JE, Hachulla E, Le Guern V, Saraux A, Morel J, Salliot C, Tournadre A, Soubrier M. Dubost JJ, et al. Among authors: couderc m. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):140-145. doi: 10.55563/clinexprheumatol/uxlsh3. Epub 2021 Dec 15. Clin Exp Rheumatol. 2021. PMID: 34919043 Free article.
144 results